Morrison & Foerster LLP
Antibody formulation
The invention provides a stable aqueous pharmaceutical formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.0 to about 6.0, and an optional surfactant, methods for making such a formulation, and methods of using such a formulation.
Genentech, Inc.
A A A A A C A A A A A A A A A A C A A C A A A A A
A61P A61P A61K A61P A61P C07K A61K A61P A61K A61P A61P A61K A61P A61J A61P A61P C07K A61P A61P C07K A61K A61P A61K A61K A61J
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional additional inventional inventional additional inventional inventional
Megan Hong Timothy J. Mary Yatin R.
Li Liu Kamerzell Cromwell Gokarn